| Carnival [CCL] - Last Close: $17.16 Carnival is rallying on an analyst upgrade. This morning, Jefferies analyst David Katz upgraded CCL from "hold" to "buy" and raised his price target on the stock from $9 to $25. Tigress Financial also released a note on Carnival, reiterating its "buy" rating and increasing its price target from $13 to $23. CCL has been performing well over the last few days after reporting its latest quarterly earnings figures on Monday. CCL is leading the S&P 500 with a 3.0% gain in today's premarket. My Take: CCL has been on a tear since the beginning of May. This stock could be a dark horse value play, and it could generate substantial revenue growth if the cruising sector snaps out of its post-pandemic funk this Summer. Renalytix [RNLX] - Last Close: $2.07 A recent regulatory decision just gave Renalytix a big boost. Thursday evening, the FDA granted de novo marketing approval for the firm's KidneyIntelX.dkd prognostic test. The test supports care management in adults with type 2 diabetes and early-stage chronic kidney disease, according to a company statement. The authorization will help the company increase test adoption, broaden insurance coverage, and provide additional benefits. RNLX is up 33.3% on the news. My Take: RNLX is on pace to close above a key resistance point at $2.50, so today's rally could push the stock into a new trading range if it can hold onto its gains. . Top FInancial [TOP] - Last Close: $7.80 Social media traders are boosting shares of TOP. The stock jumped 38.0% on Thursday in what appears to be the latest edition of "meme stock" rally. TOP's Thursday rally came with unusually high volume, and the ticker was the top trending stock on StockTwits & Twitter yesterday. The company reported its full-year financial results this morning, and the rally is continuing in the premarket. TOP reported YoY revenue growth of 24% and decreased its margin in the fiscal year ended March 31, 2023. The continued momentum lifted TOP to a 26.5% gain in Friday's premarket. My Take: I wouldn't put a lot of faith in this rally. TOP is another shady, China-based company that seems to rally and crash without any explanation. Steer clear or risk getting caught holding the bag. Bright Health Group [BHG] - Last Close: $10.92 Bright Health Group just landed a huge deal. This morning, the company said it has agreed to sell it California Medicare Advantage business to Molina Healthcare [MOH] for $600 million cash. Bright Health says it expected to complete the deal by early 2024, subject to regulatory approval and closing conditions. The company will use the sale's proceeds to fulfill obligations to lenders and reduce liabilities in its discontinued ACA insurance business. Additionally, Bright Health's Consumer Care Delivery business will enter into a provider agreement with Molina to serve Medicaid and ACA Marketplace populations in FL & TX starting in 2024. BHG is up 26.2% in response to the news. My Take: BHG still has big problems ahead of it. I don't think it's a good sign that they're selling these assets to cover debts and shore up liabilities. Plus, the chart is very, very ugly. GainersPrivaterra Acquisiton [PMGMU] >> +31.2%Lion Group Holdings [LGHL] >> +12.3%Cymabay Therapeutics [CBAY] >> +15.1%Comera Life Sciences [CMRA] >> +14.5%DeclinersUnicycive Therapeutics [UNCY] >> (23.6%) Paltalk [PALT] >> (23.0%)Guardion Health [GHSI] >> (18.7%)Root [ROOT] >> (18.2%) Constellation Brands, Inc. [STZ] ... Am PCE index [May] ... 8:30a Chicago Business Barometer [Jun] ... 9:45a Consumer sentiment [Jun] ... 10:00a | 